ABCB1 and cancer: Since then, a number of formulations have been designed to encapsulate a single anti-cancer drug in combination with a chemosensitizer, an anti-cancer drug with a P-glycoprotein inhibitor, or a combination of two anti-cancer drugs that work synergistically [23,24,25].